Andrew M Riley - Publications

Affiliations: 
Pharmacology University of Oxford, Oxford, United Kingdom 

75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Márquez-Moñino MÁ, Ortega-García R, Shipton ML, Franco-Echevarría E, Riley AM, Sanz-Aparicio J, Potter BVL, González B. Multiple substrate recognition by yeast diadenosine and diphosphoinositol polyphosphate phosphohydrolase through phosphate clamping. Science Advances. 7. PMID 33893105 DOI: 10.1126/sciadv.abf6744  0.56
2021 Whitfield H, Hemmings AM, Mills SJ, Baker K, White G, Rushworth S, Riley AM, Potter BVL, Brearley CA. Allosteric Site on SHIP2 Identified Through Fluorescent Ligand Screening and Crystallography: A Potential New Target for Intervention. Journal of Medicinal Chemistry. PMID 33724834 DOI: 10.1021/acs.jmedchem.0c01944  0.56
2020 Chin AC, Gao Z, Riley AM, Furkert D, Wittwer C, Dutta A, Rojas T, Semenza ER, Felder RA, Pluznick JL, Jessen HJ, Fiedler D, Potter BVL, Snyder SH, Fu C. The inositol pyrophosphate 5-InsP drives sodium-potassium pump degradation by relieving an autoinhibitory domain of PI3K p85α. Science Advances. 6. PMID 33115740 DOI: 10.1126/sciadv.abb8542  0.56
2020 Whitfield H, White G, Sprigg C, Riley AM, Potter BVL, Hemmings AM, Brearley CA. An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphosphoinositol phosphate levels. The Biochemical Journal. 477: 2621-2638. PMID 32706850 DOI: 10.1042/Bcj20200423  0.56
2020 Shipton M, Riley AM, Rossi AM, Brearley CA, Taylor CW, Potter BVL. Both D- and L-glucose polyphosphates mimic D-myo-inositol 1,4,5-trisphosphate: new synthetic agonists and partial agonists at the Ins(1,4,5)P3 receptor. Journal of Medicinal Chemistry. PMID 32286062 DOI: 10.1021/Acs.Jmedchem.0C00215  0.56
2020 White G, Prior C, Mills SJ, Baker K, Whitfield H, Riley AM, Oganesyan VS, Potter BVL, Brearley CA. Regioisomeric Family of Novel Fluorescent Substrates for SHIP2. Acs Medicinal Chemistry Letters. 11: 309-315. PMID 32184962 DOI: 10.1021/Acsmedchemlett.9B00368  0.56
2019 Riley AM, Wang H, Shears SB, Potter BVL. Synthesis of an α-phosphono-α,α-difluoroacetamide analogue of the diphosphoinositol pentakisphosphate 5-InsP. Medchemcomm. 10: 1165-1172. PMID 31391889 DOI: 10.1039/C9Md00163H  0.56
2019 Riley AM, Wang H, Shears SB, Potter BVL. Synthesis of an alpha-phosphono-alpha , alpha-difluoroacetamide analogue of the diphosphoinositol pentakisphosphate 5-InsP7. Medchemcomm. 10: 1165-1172. DOI: 10.2210/Pdb6N5C/Pdb  0.56
2018 Brehm MA, Klemm U, Rehbach C, Erdmann N, Kolšek K, Lin H, Aponte-Santamaría C, Gräter F, Rauch BH, Riley AM, Mayr GW, Potter BVL, Windhorst S. Inositol hexakisphosphate increases the size of platelet aggregates. Biochemical Pharmacology. PMID 30557554 DOI: 10.1016/J.Bcp.2018.12.011  0.56
2018 Whitfield H, Gilmartin M, Baker K, Riley AM, Godage HY, Potter BVL, Hemmings AM, Brearley CA. A Fluorescent Probe Identifies Active Site Ligands of Inositol Pentakisphosphate 2-Kinase. Journal of Medicinal Chemistry. PMID 30160967 DOI: 10.1021/Acs.Jmedchem.8B01022  0.56
2018 Riley AM, Unterlass J, Konieczny V, Taylor CW, Helleday T, Potter BVL. A synthetic diphosphoinositol phosphate analogue of inositol trisphosphate. Medchemcomm. 9: 1105-1113. PMID 30079174 DOI: 10.1039/C8Md00149A  0.56
2018 Whitfield H, Riley AM, Diogenous S, Godage HY, Potter BVL, Brearley CA. Simple synthesis of P-labelled inositol hexakisphosphates for study of phosphate transformations. Plant and Soil. 427: 149-161. PMID 29880988 DOI: 10.1007/S11104-017-3315-9  0.56
2016 Raimondi C, Calleja V, Ferro R, Fantin A, Riley AM, Potter BV, Brennan CH, Maffucci T, Larijani B, Falasca M. A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion. Scientific Reports. 6: 26142. PMID 27199173 DOI: 10.1038/Srep26142  0.56
2016 Watson PJ, Millard CJ, Riley AM, Robertson NS, Wright LC, Godage HY, Cowley SM, Jamieson AG, Potter BV, Schwabe JW. Insights into the activation mechanism of class I HDAC complexes by inositol phosphates. Nature Communications. 7: 11262. PMID 27109927 DOI: 10.1038/Ncomms11262  0.52
2015 Swarbrick JM, Riley AM, Mills SJ, Potter BVL. Designer small molecules to target calcium signalling Biochemical Society Transactions. 43: 417-425. PMID 26009185 DOI: 10.1042/Bst20140293  0.52
2014 Wang H, Godage HY, Riley AM, Weaver JD, Shears SB, Potter BV. Synthetic inositol phosphate analogs reveal that PPIP5K2 has a surface-mounted substrate capture site that is a target for drug discovery. Chemistry & Biology. 21: 689-99. PMID 24768307 DOI: 10.1016/J.Chembiol.2014.03.009  0.52
2014 Pulloor NK, Nair S, Kostic AD, Bist P, Weaver JD, Riley AM, Tyagi R, Uchil PD, York JD, Snyder SH, García-Sastre A, Potter BV, Lin R, Shears SB, Xavier RJ, et al. Human genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon response. Plos Pathogens. 10: e1003981. PMID 24586175 DOI: 10.1371/Journal.Ppat.1003981  0.52
2014 Riley AM, Windhorst S, Lin HY, Potter BV. Cellular internalisation of an inositol phosphate visualised by using fluorescent InsP5. Chembiochem : a European Journal of Chemical Biology. 15: 57-67. PMID 24311195 DOI: 10.1002/Cbic.201300583  0.56
2013 Saleem H, Tovey SC, Riley AM, Potter BV, Taylor CW. Stimulation of inositol 1,4,5-trisphosphate (IP3) receptor subtypes by adenophostin A and its analogues. Plos One. 8: e58027. PMID 23469136 DOI: 10.1371/Journal.Pone.0058027  0.52
2013 Godage HY, Riley AM, Woodman TJ, Thomas MP, Mahon MF, Potter BV. Regioselective opening of myo-inositol orthoesters: mechanism and synthetic utility. The Journal of Organic Chemistry. 78: 2275-88. PMID 23438216 DOI: 10.1021/Jo3027774  0.56
2013 Saleem H, Tovey SC, Rahman T, Riley AM, Potter BV, Taylor CW. Stimulation of inositol 1,4,5-trisphosphate (IP3) receptor subtypes by analogues of IP3. Plos One. 8: e54877. PMID 23372785 DOI: 10.1371/Journal.Pone.0054877  0.52
2013 Khan SA, Rossi AM, Riley AM, Potter BV, Taylor CW. Subtype-selective regulation of IP(3) receptors by thimerosal via cysteine residues within the IP(3)-binding core and suppressor domain. The Biochemical Journal. 451: 177-84. PMID 23282150 DOI: 10.1042/Bj20121600  0.52
2013 Veiga N, Torres J, Macho I, Gómez K, Godage HY, Riley AM, Potter BV, González G, Kremer C. Inframolecular acid-base and coordination properties towards Na(+) and Mg(2+) of myo-inositol 1,3,4,5,6-pentakisphosphate: a structural approach to biologically relevant species. Dalton Transactions (Cambridge, England : 2003). 42: 6021-32. PMID 23183928 DOI: 10.1039/C2Dt31807E  0.56
2012 Grint T, Riley AM, Mills SJ, Potter BV, Safrany ST. Fibrinogen - a possible extracellular target for inositol phosphates. Messenger (Los Angeles, Calif. : Print). 1: 160-166. PMID 24749013 DOI: 10.1166/Msr.2012.1014  0.56
2012 Riley AM, Wang H, Weaver JD, Shears SB, Potter BV. First synthetic analogues of diphosphoinositol polyphosphates: interaction with PP-InsP5 kinase. Chemical Communications (Cambridge, England). 48: 11292-4. PMID 23032903 DOI: 10.1039/C2Cc36044F  0.52
2012 Turner BL, Cheesman AW, Godage HY, Riley AM, Potter BV. Determination of neo- and D-chiro-inositol hexakisphosphate in soils by solution 31P NMR spectroscopy. Environmental Science & Technology. 46: 4994-5002. PMID 22489788 DOI: 10.1021/Es204446Z  0.52
2012 Mills SJ, Persson C, Cozier G, Thomas MP, Trésaugues L, Erneux C, Riley AM, Nordlund P, Potter BV. A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery. Acs Chemical Biology. 7: 822-8. PMID 22330088 DOI: 10.1021/Cb200494D  0.52
2012 Sureshan KM, Riley AM, Thomas MP, Tovey SC, Taylor CW, Potter BV. Contribution of phosphates and adenine to the potency of adenophostins at the IP₃ receptor: synthesis of all possible bisphosphates of adenophostin A. Journal of Medicinal Chemistry. 55: 1706-20. PMID 22248345 DOI: 10.1021/Jm201571P  0.52
2012 Turner BL, Cheesman AW, Godage HY, Riley AM, Potter BVL. Response to comment on "determination of neo - And D-chiro-inositol hexakisphosphate in soils by solution 31P NMR spectroscopy" Environmental Science and Technology. 46: 11480-11481. DOI: 10.1021/Es303737M  0.52
2010 Rossi AM, Riley AM, Potter BV, Taylor CW. Adenophostins: High-Affinity Agonists of IP(3) Receptors. Current Topics in Membranes. 66: 209-33. PMID 22353482 DOI: 10.1016/S1063-5823(10)66010-3  0.52
2010 Rossi AM, Sureshan KM, Riley AM, Potter VL, Taylor CW. Selective determinants of inositol 1,4,5-trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5-trisphosphate receptors. British Journal of Pharmacology. 161: 1070-85. PMID 20977457 DOI: 10.1111/J.1476-5381.2010.00947.X  0.52
2010 Ding Z, Rossi AM, Riley AM, Rahman T, Potter BV, Taylor CW. Binding of inositol 1,4,5-trisphosphate (IP3) and adenophostin A to the N-terminal region of the IP3 receptor: thermodynamic analysis using fluorescence polarization with a novel IP3 receptor ligand. Molecular Pharmacology. 77: 995-1004. PMID 20215561 DOI: 10.1124/Mol.109.062596  0.52
2009 Rossi AM, Riley AM, Tovey SC, Rahman T, Dellis O, Taylor EJ, Veresov VG, Potter BV, Taylor CW. Synthetic partial agonists reveal key steps in IP3 receptor activation. Nature Chemical Biology. 5: 631-9. PMID 19668195 DOI: 10.1038/Nchembio.195  0.52
2009 Veiga N, Torres J, Godage HY, Riley AM, Domínguez S, Potter BV, Díaz A, Kremer C. The behaviour of inositol 1,3,4,5,6-pentakisphosphate in the presence of the major biological metal cations. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 14: 1001-13. PMID 19415348 DOI: 10.1007/S00775-009-0510-Z  0.56
2009 Sureshan KM, Riley AM, Rossi AM, Tovey SC, Dedos SG, Taylor CW, Potter BV. Activation of IP(3) receptors by synthetic bisphosphate ligands. Chemical Communications (Cambridge, England). 1204-6. PMID 19240874 DOI: 10.1039/B819328B  0.52
2006 Godage HY, Riley AM, Woodman TJ, Potter BV. Regioselective hydrolysis of myo-inositol 1,3,5-orthobenzoate via a 1,2-bridged 2'-phenyl-1',3'-dioxolan-2'-ylium ion provides a rapid route to the anticancer agent Ins(1,3,4,5,6)P5. Chemical Communications (Cambridge, England). 2989-91. PMID 16832513 DOI: 10.1039/B605392K  0.56
2006 Riley AM, Trusselle M, Kuad P, Borkovec M, Cho J, Choi JH, Qian X, Shears SB, Spiess B, Potter BV. scyllo-inositol pentakisphosphate as an analogue of myo-inositol 1,3,4,5,6-pentakisphosphate: chemical synthesis, physicochemistry and biological applications. Chembiochem : a European Journal of Chemical Biology. 7: 1114-22. PMID 16755629 DOI: 10.1002/Cbic.200600037  0.52
2006 Riley AM, Deleu S, Qian X, Mitchell J, Chung SK, Adelt S, Vogel G, Potter BV, Shears SB. On the contribution of stereochemistry to human ITPK1 specificity: Ins(1,4,5,6)P4 is not a physiologic substrate. Febs Letters. 580: 324-30. PMID 16376887 DOI: 10.1016/J.Febslet.2005.12.016  0.56
2005 Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, Saiardi A, Godage HY, Rossi C, Broggini M, Iacobelli S, Potter BV, Innocenti P, Falasca M. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Research. 65: 8339-49. PMID 16166311 DOI: 10.1158/0008-5472.Can-05-0121  0.56
2005 Poinas A, Backers K, Riley AM, Mills SJ, Moreau C, Potter BV, Erneux C. Interaction of the catalytic domain of inositol 1,4,5-trisphosphate 3-kinase A with inositol phosphate analogues. Chembiochem : a European Journal of Chemical Biology. 6: 1449-57. PMID 15997461 DOI: 10.1002/Cbic.200400443  0.56
2004 Solyakov L, Cain K, Tracey BM, Jukes R, Riley AM, Potter BV, Tobin AB. Regulation of casein kinase-2 (CK2) activity by inositol phosphates. The Journal of Biological Chemistry. 279: 43403-10. PMID 15297462 DOI: 10.1074/Jbc.M403239200  0.56
2004 Gregory RB, Hughes R, Riley AM, Potter BV, Wilcox RA, Barritt GJ. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes. The Biochemical Journal. 381: 519-26. PMID 15169542 DOI: 10.1042/Bj20040637  0.56
2004 Riley AM, Dozol H, Spiess B, Potter BV. 2-O-(2-Aminoethyl)-myo-inositol 1,4,5-trisphosphate as a novel ligand for conjugation: physicochemical properties and synthesis of a new Ins(1,4,5)P(3) affinity matrix. Biochemical and Biophysical Research Communications. 318: 444-52. PMID 15120621 DOI: 10.1016/J.Bbrc.2004.04.051  0.56
2004 Riley AM, Laude AJ, Taylor CW, Potter BV. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors. Bioconjugate Chemistry. 15: 278-89. PMID 15025523 DOI: 10.1021/Bc034214S  0.56
2004 Piccolo E, Vignati S, Maffucci T, Innominato PF, Riley AM, Potter BV, Pandolfi PP, Broggini M, Iacobelli S, Innocenti P, Falasca M. Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway. Oncogene. 23: 1754-65. PMID 14755253 DOI: 10.1038/Sj.Onc.1207296  0.56
2003 Mills SJ, Riley AM, Liu C, Mahon MF, Potter BV. A definitive synthesis of D-myo-inositol 1,4,5,6-tetrakisphosphate and its enantiomer D-myo-inositol 3,4,5,6-tetrakisphosphate from a novel butane-2,3-diacetal-protected inositol. Chemistry (Weinheim An Der Bergstrasse, Germany). 9: 6207-14. PMID 14679531 DOI: 10.1002/Chem.200305207  0.52
2003 Rosenberg HJ, Riley AM, Laude AJ, Taylor CW, Potter BV. Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction. Journal of Medicinal Chemistry. 46: 4860-71. PMID 14584937 DOI: 10.1021/Jm030883F  0.56
2003 Wagner GK, Riley AM, Rosenberg HJ, Taylor CW, Guse AH, Potter BV. Analogues of cyclic adenosine 5'-diphosphate ribose and adenophostin A, nucleotides in cellular signal transduction. Nucleic Acids Research. Supplement (2001). 1-2. PMID 14510350  0.56
2003 Whitley P, Reaves BJ, Hashimoto M, Riley AM, Potter BV, Holman GD. Identification of mammalian Vps24p as an effector of phosphatidylinositol 3,5-bisphosphate-dependent endosome compartmentalization. The Journal of Biological Chemistry. 278: 38786-95. PMID 12878588 DOI: 10.1074/Jbc.M306864200  0.56
2002 Riley AM, Morris SA, Nerou EP, Correa V, Potter BV, Taylor CW. Interactions of inositol 1,4,5-trisphosphate (IP(3)) receptors with synthetic poly(ethylene glycol)-linked dimers of IP(3) suggest close spacing of the IP(3)-binding sites. The Journal of Biological Chemistry. 277: 40290-5. PMID 12183463 DOI: 10.1074/jbc.M206925200  0.56
2002 Morris SA, Nerou EP, Riley AM, Potter BV, Taylor CW. Determinants of adenophostin A binding to inositol trisphosphate receptors. The Biochemical Journal. 367: 113-20. PMID 12088506 DOI: 10.1042/Bj20020675  0.56
2002 Riley AM, Jenkins DJ, Marwood RD, Potter BVL. Synthesis of glucopyranoside-based ligands for D-myo-inositol 1,4,5-trisphosphate receptors Carbohydrate Research. 337: 1067-1082. PMID 12062522 DOI: 10.1016/S0008-6215(02)00103-9  0.52
2002 Ho MW, Yang X, Carew MA, Zhang T, Hua L, Kwon YU, Chung SK, Adelt S, Vogel G, Riley AM, Potter BV, Shears SB. Regulation of Ins(3,4,5,6)P(4) signaling by a reversible kinase/phosphatase. Current Biology : Cb. 12: 477-82. PMID 11909533 DOI: 10.1016/S0960-9822(02)00713-3  0.56
2002 Parekh AB, Riley AM, Potter BV. Adenophostin A and ribophostin, but not inositol 1,4,5-trisphosphate or manno-adenophostin, activate the Ca2+ release-activated Ca2+ current, I(CRAC), in weak intracellular Ca2+ buffer. The Biochemical Journal. 361: 133-41. PMID 11742538 DOI: 10.1042/0264-6021:3610133  0.56
2001 Rosenberg HJ, Riley AM, Marwood RD, Correa V, Taylor CW, Potter BVL. Xylopyranoside-based agonists of D-myo-inositol 1,4,5-trisphosphate receptors: synthesis and effect of stereochemistry on biological activity. Carbohydrate Research. 332: 53-66. PMID 11403088 DOI: 10.1016/S0008-6215(01)00067-2  0.36
2000 Hermosura MC, Takeuchi H, Fleig A, Riley AM, Potter BV, Hirata M, Penner R. InsP4 facilitates store-operated calcium influx by inhibition of InsP3 5-phosphatase. Nature. 408: 735-40. PMID 11130077 DOI: 10.1038/35047115  0.52
2000 Murphy CT, Riley AM, Mills SJ, Lindley CJ, Potter BV, Westwick J. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor. Molecular Pharmacology. 57: 595-601. PMID 10692501 DOI: 10.1124/Mol.57.3.595  0.52
2000 Riley AM, Potter BVL. Poly(ethylene glycol)-linked dimers of D-myo-inositol 1,4,5-trisphosphate Chemical Communications. 2000: 983-984. DOI: 10.1039/B002312O  0.56
2000 Marwood RD, Riley AM, Jenkins DJ, Potter BVL. Synthesis of adenophostin A and congeners modified at glucose Journal of the Chemical Society, Perkin Transactions 1. 1935-1947. DOI: 10.1039/B001386M  0.52
1999 Yang X, Rudolf M, Carew MA, Yoshida M, Nerreter V, Riley AM, Chung SK, Bruzik KS, Potter BV, Schultz C, Shears SB. Inositol 1,3,4-trisphosphate acts in vivo as a specific regulator of cellular signaling by inositol 3,4,5,6-tetrakisphosphate. The Journal of Biological Chemistry. 274: 18973-80. PMID 10383396 DOI: 10.1074/Jbc.274.27.18973  0.56
1999 Hirst PH, Riley AM, Mills SJ, Spiers ID, Poyner DR, Freeman S, Potter BV, Smith AW. Inositol polyphosphate-mediated iron transport in Pseudomonas aeruginosa. Journal of Applied Microbiology. 86: 537-43. PMID 10196759 DOI: 10.1046/J.1365-2672.1999.00697.X  0.56
1999 Marwood RD, Riley AM, Correa V, Taylor CW, Potter BV. Simplification of adenophostin A defines a minimal structure for potent glucopyranoside-based mimics of D-myo-inositol 1,4,5-trisphosphate. Bioorganic & Medicinal Chemistry Letters. 9: 453-8. PMID 10091701 DOI: 10.1016/S0960-894X(99)00006-2  0.36
1999 Beecroft MD, Marchant JS, Riley AM, Van Straten NC, Van der Marel GA, Van Boom JH, Potter BV, Taylor CW. Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy. Molecular Pharmacology. 55: 109-17. PMID 9882704 DOI: 10.1124/Mol.55.1.109  0.52
1998 Garrett SW, Liu C, Riley AM, Potter BVL. Rapid and practical synthesis of D-myo-inositol 1,4,5-trisphosphate Journal of the Chemical Society-Perkin Transactions 1. 1998: 1367-1368. DOI: 10.1039/A801874J  0.56
1998 Riley AM, Potter BV. l-α-Phosphatidyl-d-myo-inositol 3,5-bisphosphate: total synthesis of a new inositol phospholipid via myo-inositol orthoacetate Tetrahedron Letters. 39: 6769-6772. DOI: 10.1016/S0040-4039(98)01422-1  0.4
1998 Riley AM, Jenkins DJ, Potter BVL. A concise synthesis of neo-inositol Carbohydrate Research. 314: 277-281. DOI: 10.1016/S0008-6215(98)00317-6  0.52
1997 Murphy CT, Riley AM, Lindley CJ, Jenkins DJ, Westwick J, Potter BVL. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: Recognition by cerebellar and platelet inositol-1,4,5- trisphosphate receptors Molecular Pharmacology. 52: 741-748. PMID 9380038 DOI: 10.1124/Mol.52.4.741  0.52
1997 Hirata M, Takeuchi H, Riley AM, Mills SJ, Watanabe Y, Potter BV. Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate. The Biochemical Journal. 328: 93-8. PMID 9359838  0.52
1997 Guédat P, Schlewer G, Krempp E, Riley AM, Potter BVL, Spiess B. Investigation of the inframolecular acid-base properties of D-myo-inositol 1,3,4,5-tetrakisphosphate and DL-myo-inositol 1,2,4,5-tetrakisphosphate Chemical Communications. 1997: 625-626. DOI: 10.1039/A608347A  0.56
1997 Riley AM, Mahon MF, Potter BVL. Einfache Synthese der Enantiomere von myo-Inosit-1,3,4,5-tetrakisphosphat durch direkte chirale Desymmetrisierung von myo-Inositorthoformiat Angewandte Chemie. 109: 1583-1585. DOI: 10.1002/Ange.19971091341  0.56
1996 Potter BVL, Riley AM, Mills SJ, Jenkins DJ, Liu C, Lampe D. Synthetic Modulators of the Polyphosphoinositide Pathway of Signal Transduction Phosphorus Sulfur and Silicon and the Related Elements. 109: 329-332. DOI: 10.1080/10426509608046265  0.56
1996 Jenkins DJ, Riley AM, Potter BVL. Chiral cyclopentane-based mimics of D-myo-inositol 1,4,5-trisphosphate from D-glucose Journal of Organic Chemistry. 61: 7719-7726. DOI: 10.1021/Jo961158Y  0.52
1996 Riley AM, Murphy CT, Lindley CJ, Westwick J, Potter BVL. 6-Deoxy-6-hydroxymethyl scyllo-inositol 1,2,4-trisphosphate: A potent agonist at the inositol 1,4,5-trisphosphate receptor Bioorganic and Medicinal Chemistry Letters. 6: 2197-2200. DOI: 10.1016/0960-894X(96)00399-X  0.52
1995 Mills SJ, Riley AM, Murphy CT, Bullock AJ, Westwick J, Potter BV. Myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3,4-trisphosphorothioate: New synthetic Ca2+-mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor Bioorganic and Medicinal Chemistry Letters. 5: 203-208. DOI: 10.1016/0960-894X(95)00012-I  0.52
1994 Riley AM, Payne R, Potter BVL. Unambiguous Total Synthesis of the Enantiomers of myo-Inositol 1,3,4-Trisphosphate: 1L-myo-Inositol 1,3,4-Trisphosphate Mobilizes Intracellular Ca2+ in Limulus Photoreceptors Journal of Medicinal Chemistry. 37: 3918-3927. PMID 7966153 DOI: 10.1021/Jm00049A011  0.56
Show low-probability matches.